Literature DB >> 2261376

Late cardiac effects after mantle radiotherapy in patients with Hodgkin's disease.

A Gustavsson1, J Eskilsson, T Landberg, G Svahn-Tapper, T White, P Wollmer, M Akerman.   

Abstract

Twenty-five patients (21-45 years old) treated for Hodgkin's disease with mantle radiotherapy but no chemotherapy underwent cardiac testing with myocardial scintigraphy during exercise, Echo-Doppler cardiography and CT-examination, 10-20 years after treatment. Four of twenty-six (15%) young patients had serious cardiac complications after mantle therapy, and reduced systolic and/or diastolic function; and minor valvular disturbances were often found. One 36-year-old female died of myocardial infarction 4 years after therapy, one 39-year-old male had two non-lethal infarctions after 14 years, one 36-year-old male with no symptoms had severe reversible ischemia and three proximal coronary artery stenoses, and one 32-year-old female with constrictive pericarditis had pericardeictomy 14 years after therapy. In 23/24 patients the pericardial thickness was normal and no pericardial effusion was found. 23/24 patients had normal working capacity, but myocardial scintigraphy was normal in only 9 patients. 11/25 patients had reduced systolic function and in 12/24 patients the diastolic function was reduced. 11/25 patients had abnormal valvular or subvalvular structures. Valvular stenosis was not found but aortic, mitral and tricuspidal regurgitations were found in 1/25, 9/25 and 22/25, respectively. In all but two cases the regurgitations were mild. We conclude that mediastinal irradiation must be considered a risk factor for cardiac disease. It may be advisable to reduce other risk factors in these patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2261376     DOI: 10.1093/oxfordjournals.annonc.a057774

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  12 in total

1.  Myocardial perfusion damage after mediastinal irradiation for Hodgkin's disease: a thallium-201 single photon emission tomography study.

Authors:  C Maunoury; J Y Pierga; H Valette; G Tchernia; J M Cosset; A Desgrez
Journal:  Eur J Nucl Med       Date:  1992

2.  Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer.

Authors:  Andre Konski; Tianyu Li; Michael Christensen; Jonathan D Cheng; Jian Q Yu; Kevin Crawford; Oleh Haluszka; Jeffrey Tokar; Walter Scott; Neal J Meropol; Steven J Cohen; Alan Maurer; Gary M Freedman
Journal:  Radiother Oncol       Date:  2012-06-07       Impact factor: 6.280

3.  Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: an echocardiographic study.

Authors:  M B Lund; H Ihlen; B M Voss; A F Abrahamsen; O Nome; J Kongerud; M Stugaard; K Forfang
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

Review 4.  Imaging radiation-induced normal tissue injury.

Authors:  Mike E Robbins; Judy K Brunso-Bechtold; Ann M Peiffer; Christina I Tsien; Janet E Bailey; Lawrence B Marks
Journal:  Radiat Res       Date:  2012-02-21       Impact factor: 2.841

5.  Radiotherapy, left-sided breast cancer, and ischaemic heart disease.

Authors:  R E Smith; H J Dobbs; J F Martin
Journal:  Br Heart J       Date:  1993-06

6.  Impaired vascular function in asymptomatic young adult survivors of Hodgkin Lymphoma following mediastinal radiation.

Authors:  Shayna Zelcer; Breanna Chen; Joy Mangel; Olga Vujovic; Heather R Thiessen-Philbrook; Michael Reider; Farid H Mahmud
Journal:  J Cancer Surviv       Date:  2010-07-21       Impact factor: 4.442

Review 7.  Myocardial infarction in young patients with Hodgkin's disease--potential pathogenic role of radiotherapy, chemotherapy, and splenectomy.

Authors:  K H Scholz; C Herrmann; U Tebbe; J M Chemnitius; U Helmchen; H Kreuzer
Journal:  Clin Investig       Date:  1993-01

Review 8.  Cardiovascular complications of radiation therapy for thoracic malignancies: the role for non-invasive imaging for detection of cardiovascular disease.

Authors:  John D Groarke; Paul L Nguyen; Anju Nohria; Roberto Ferrari; Susan Cheng; Javid Moslehi
Journal:  Eur Heart J       Date:  2013-05-10       Impact factor: 29.983

9.  Hepatocyte growth factor protects endothelial cells against gamma ray irradiation-induced damage.

Authors:  Shun-Ying Hu; Hai-Feng Duan; Qing-Fang Li; Yue-Feng Yang; Jin-Long Chen; Li-Sheng Wang; Hua Wang
Journal:  Acta Pharmacol Sin       Date:  2009-09-14       Impact factor: 6.150

10.  What's new in target volume definition for radiologists in ICRU Report 71? How can the ICRU volume definitions be integrated in clinical practice?

Authors:  Anne Kiil Berthelsen; Jane Dobbs; Elisabeth Kjellén; Torsten Landberg; Torgil R Möller; Per Nilsson; Lena Specht; André Wambersie
Journal:  Cancer Imaging       Date:  2007-06-11       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.